News

Cardiac Cell Therapy: Redefining the Path to Cardiac Repair

(b) Confocal micrographs of heart tissue sections from Ccr2-RFP × Cx3cr1-GFP mice 10 days post-ischemia-reperfusion (I–R) injury show the infarct border zone versus remote myocardium. A biotin-conjugated CHP, detected with a streptavidin-conjugated Alexa 647 secondary antibody (purple), visualized immature or denatured collagen, pinpointing areas of active ECM remodeling. Stem cell therapy has long been...
View Details

Antioxidant-loaded sEVs Boost Collagen Turnover in Atrophic Muscles

Antioxidant-loaded small extracellular vesicles (sEVs) enhance muscle regeneration and accelerate collagen turnover, offering a promising cell-free therapy for skeletal muscle atrophy. Using Collagen Hybridizing Peptides (CHPs), researchers quantified collagen remodeling and showed how sEVs stimulate recovery in atrophic muscles. Learn how this innovative approach combines antioxidant-loaded sEVs and CHPs to drive tissue repair and...
View Details

Using B-CHP to Stain for Damaged Collagen Illuminates Impacts of Retinal + Retinol Analog Treatment on UV Exposed Skin

UV light exposure causes skin damage, leading to wrinkles, roughness, and accelerated aging. While retinoids are effective anti-aging treatments, they often cause skin irritation. This study highlights a breakthrough alternative using retinal (RAL), combined with plant-derived retinol analogs like bakuchiol (BAK) and Vigna aconitifolia extract (VAE). Research on UV-damaged skin demonstrated that this combination...
View Details

Metformin Pre-Treatment Improves ECM Remodeling and Collagen Turnover, Highlighted by CHP Use in Muscle Fibrosis

Metformin pre-treatment enhances extracellular matrix (ECM) remodeling and reduces muscle fibrosis during bed rest, with critical insights provided by collagen hybridizing peptides (CHPs). By increasing type I myofiber size and decreasing cellular senescence markers, metformin promotes healthier muscle recovery and improves collagen turnover. This approach, supported by CHP technology, shows promise as an anti-inflammatory...
View Details

CHPs enable precise detection of ECM depletion in solid tumors, offering researchers critical insights into how stromal-targeted therapies improve T cell infiltration and immunotherapy efficacy in PDAC.

While chimeric antigen T (CAR-T) cells have shown immense promise as a cancer therapeutic, they have limited efficacy in treating solid tumors. This is due to immune exclusion, whereby physical barriers such as stromal cells woven into dense extracellular matrices prevent anti-cancer immune cells from reaching the tumor.
View Details

Can a Simple Feedback Loop Explain Skin Development and Repair?

Fibroblasts are central architects of our skin, coordinating tissue growth and ECM production. But how do these cells know when to stop growing and start building the structural framework of the skin? In a recent study, researchers discovered a negative feedback loop between fibroblast proliferation and ECM deposition. Using live imaging and Collagen Hybridizing...
View Details

How can CHPs Improve Our Understanding of Inflammation?

Chronic inflammation can damage previously healthy tissues and organs, leading to a number of ailments including cardiovascular disease, rheumatoid arthritis, and lupus. Activation and deactivation of calcium-importing ion channel TRPV4 modulates inflammation through multiple mechanisms. Indeed, it has been shown that TRPV4 antagonists reduce production of pro-inflammatory cytokines, while TRPV4 activation shifts macrophages to...
View Details